AtifKhanMD

Attending, Memorial Sloan Kettering Cancer Center

Overview of Dr. Khan

Dr. Atif Khan is a radiation oncologist in New York, NY and is affiliated with multiple hospitals in the area, including Memorial Sloan Kettering Cancer Center, Robert Wood Johnson University Hospital, Memorial Sloan Kettering Monmouth, and Memorial Hospital for Cancer and allied Diseases. He received his medical degree from Aga Khan Medical College and has been in practice 21 years. He is one of 106 doctors at Memorial Sloan Kettering Cancer Center and one of 32 doctors at Robert Wood Johnson University Hospital who specialize in Radiation Oncology. He has more than 100 publications and over 500 citings.

Office
1275 York Avenue
New York, NY 10065
Book by Phone+1(231) 680-2513

Education & Training

Rush University Medical CenterResidency, Radiation Oncology, 2002 - 2006
Yale-New Haven Medical CenterInternship, Internal Medicine, 2001 - 2002
Aga Khan Medical CollegeClass of 1999

Certifications & Licensure

FL State Medical License 2023 - Present
MI State Medical License 2009 - 2026
NJ State Medical License 2007 - 2025
NY State Medical License 2016 - 2025
IL State Medical License 2002 - 2017
American Board of Radiology Radiation Oncology

Clinical Trials

Study of 3-Day Partial Breast Radiation Therapy in Women With Breast Cancer Start of enrollment: 2019 Aug 30
Recruiting
Phase 2
Roles: Principal Investigator, Contact
A Study of Radiation Therapy With Pembrolizumab and Olaparib or Other Radiosensitizers in Women Who Have Triple-Negative or Hormone-Receptor Positive/Her2 Negative Breast Cancer Start of enrollment: 2021 Apr 21
Recruiting
Phase 2
Roles: Contact, Principal Investigator
A Study of an Alternative Treatment Approach (Preoperative Radiotherapy, Then Mastectomy, Then Immediate Reconstruction Surgery) in People With T4 Breast Cancer Start of enrollment: 2022 Jun 06
Recruiting
Phase 1
Roles: Contact
A Study of Rucaparib Administered With Radiation in Patients With Triple Negative Breast Cancer With an Incomplete Response Following Chemotherapy Start of enrollment: 2018 May 23
Active, not recruiting
Phase 1
Roles: Principal Investigator, Contact
Study of a Shortened Radiation Therapy Schedule in People With Breast Cancer Start of enrollment: 2020 Nov 24
Recruiting
Early Phase 1
Roles: Principal Investigator, Contact
A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue Start of enrollment: 2023 Jul 24
Recruiting
Not Applicable
Roles: Principal Investigator, Contact
A Study on Adding Precisely Targeted Radiation Therapy (Stereotactic Body Radiation Therapy) to the Usual Treatment Approach (Drug Therapy) in People With Breast Cancer Start of enrollment: 2022 Sep 06
Recruiting
Phase 2
Roles: Contact
Join now to see all

Publications & Presentations

PubMed

Increased Synthetic Cytotoxicity of Combinatorial Chemoradiation Therapy in Homologous Recombination Deficient Tumors.
Jennifer Ma, Rachna Shah, Andrew C Bell, Niamh McDermott, Xin Pei
International Journal of Radiation Oncology, Biology, Physics. 2025-03-01
Genotype-Directed Synthetic Cytotoxicity of ATR Inhibition with Radiotherapy.
Victor Ng, Sonali Sinha, Ardijana Novaj, Jennifer Ma, Niamh McDermott
Clinical Cancer Research. 2024-12-16
Contextual Framework for Understanding Treatment De-Escalation in Patients With Breast Cancer.
Atif J Khan, Giacomo Montagna
JCO Oncology Practice. 2024-11-22

Press Mentions

SABCS Session Provides Clinical Implications of New Data and Practical TakeawaysJanuary 9th, 2025
View from the Trenches Panelists Share Thoughts on Translating SABCS® Presentations into PracticeDecember 15th, 2024
Shorter Course of Radiation for Breast Cancer Will Not Affect Breast ReconstructionOctober 1st, 2024
Join now to see all